The DSRU has a unique method for conducting post-authorisation safety studied (PASS) on medicines prescribed in hospital or specialist care. This SCEM (Specialist Cohort Event Monitoring) methodology allows us to work directly with specialists and health care teams in hospitals in order to recruit patients to the observational study and collect utilisation and safety data.
We are now working on our fourth SCEM study. This method is ideal for studying the safety or utilisation of medicines that are initially prescribed in hospital or specialist care and later transferred to primary care. We work closely with specialists in the relevant therapeutic areas to understand the prescribing of the drug to be studied, in order to design a bespoke protocol that is best suited to the medicine concerned.
Further details are available here.
Back to news